BURLINGTON, Mass. (AP) _ Flexion Therapeutics Inc. (FLXN) on Thursday reported a loss of $38.2 million in its third quarter.
The Burlington, Massachusetts-based company said it had a loss of $1 per share.
The specialty pharmaceutical companies that specializes in pain relief posted revenue of $21.8 million in the period.
Flexion Therapeutics shares have increased 51% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $17.12, an increase of 20% in the last 12 months.